(Press-News.org) An analysis of data from previously published studies indicates that use of the antiplatelet drug clopidogrel for patients who have common genetic variants of a certain gene and are undergoing a procedure such as coronary stent placement have an associated increased risk for major adverse cardiovascular events, particularly development of blood clots in stents, according to a study in the October 27 issue of JAMA.
Clopidogrel, one of the most commonly prescribed medications, has been shown to reduce cardiovascular events in patients undergoing percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries). "However, there is a large degree of interindividual variability in the pharmaco-dynamic response to clopidogrel," the authors write. Data suggest its pharmacologic effect varies based on variations of the gene CYP2C19, but there is uncertainty regarding the clinical risk given by certain variations.
Jessica L. Mega, M.D., M.P.H., of Brigham and Women's Hospital and Harvard Medical School, Boston, and colleagues conducted a meta-analysis to determine the risk of major adverse cardiovascular outcomes among carriers of 1 or 2 reduced-function CYP2C19 genetic variants in patients treated with clopidogrel. The analysis included data from 9 studies and 9,685 patients (of whom 91.3 percent underwent PCI and 54.5 percent had an acute coronary syndrome), 863 experienced the composite outcome of cardiovascular death, heart attack, or stroke; and 84 patients had stent thrombosis (blood clot) among the 5,894 evaluated for such.
There were 6,923 patients (71.5 percent) with no CYP2C19 reduced-function alleles (an alternative form of a gene), 2,544 (26.3 percent) with 1 reduced-function CYP2C19 allele, and 218 (2.2 percent) with 2 reduced-function CYP2C19 alleles. "Compared with CYP2C19 noncarriers, there was a significantly increased risk of cardiovascular death, myocardial infarction, or stroke in the 26.3 percent of the overall study population who carried only 1 reduced-function CYP2C19 allele. Similarly, there was a significantly increased risk of cardiovascular death, myocardial infarction, or stroke in the 2.2 percent of the overall study population who carried 2 reduced-function CYP2C19 alleles," the researchers write.
The authors also found that both carriers of only 1 reduced-function CYP2C19 allele and carriers of 2 alleles were at significantly increased risk of stent thrombosis when compared with CYP2C19 noncarriers.
"In conclusion, the findings of this collaborative meta-analysis demonstrate that common genetic variants in the CYP2C19 gene are associated with almost 1 in 3 patients not receiving ideal protection from ischemic events when treated with standard doses of clopidogrel for PCI. Given how widely clopidogrel is used to treat patients with cardiovascular disease, determination of the optimal antiplatelet treatment doses or regimens for individual patients is needed to tailor therapy appropriately," the authors write.
(JAMA. 2010;304[16]:1821-1830. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Clopidogrel and the Reduced-Function CYP2C19 Genetic Variant
In an accompanying editorial, Valentin Fuster, M.D., Ph.D., of the Mount Sinai School of Medicine, New York, and Joseph M. Sweeny, M.D., of the Mount Sinai Medical Center, comment on the findings of this meta-analysis.
" … in patients treated with clopidogrel, the best genome-guided strategy remains to be determined. The information obtained by CYP2C19 genetic testing may be particularly useful in patients at risk of poor outcomes, either because they have already had an adverse event (e.g., stent thrombosis) or other at-risk characteristics such as diabetes mellitus, chronic renal failure, or angiographic high-risk features."
They add that until other ongoing studies that are investigating the best genome-guided strategy for higher-risk patients are completed, "clopidogrel and CYP2C19 genetic testing appear to be only a limited piece of the overall therapeutic puzzle of clopidogrel therapy and personalized medicine."
(JAMA. 2010;304[16]:1839-1840. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including author affiliations, financial disclosures, funding and support, etc.
INFORMATION:
To contact corresponding authors Jessica L. Mega, M.D., M.P.H., or Marc S. Sabatine, M.D., M.P.H., call Kevin Myron at 617-534-1605 or email kmyron@partners.org. To contact editorial co-author Valentin Fuster, M.D., Ph.D., call Ian Michaels at 212-241-9200 or email ian.michaels@mountsinai.org.
For more information, contact JAMA/Archives Media Relations at 312/464-JAMA (5262) or e-mail mediarelations@jama-archives.org.
END
Journals need to develop policies to handle the inevitable competing interests that arise when they publish papers that may bring them reprint revenue or increase their impact factors. This is the conclusion of a research article by Andreas Lundh and colleagues from the Nordic Cochrane Centre published in this weeks PLoS Medicine. An accompanying perspective by Harvey Marcovitch, ex-chair of the Committee on Publication Ethics (COPE), and an editorial from the PLoS Medicine Editors discusses this issue further, concluding that journals should apply the same degree of transparency ...
Current WHO pesticide classifications are based on toxicity in rats but basing regulation on human toxicity will make pesticide poisoning less hazardous and prevent hundreds of thousands of deaths globally without compromising agricultural needs. These are the key findings from a study by Andrew Dawson (South Asian Clinical Toxicology Research Collaboration, University of Peradeniya, Sri Lanka) and colleagues published in this week's PLoS Medicine.
The single most common means of suicide worldwide is agricultural pesticide poisoning. The authors examined the proportion ...
Nagoya, Japan, Wednesday 27 October 2010 (IUCN) – The most comprehensive assessment of the world's vertebrates confirms an extinction crisis with one-fifth of species threatened. However, the situation would be worse were it not for current global conservation efforts, according to a study launched today at the 10th Conference of the Parties to the Convention on Biological Diversity, CBD, in Nagoya, Japan.
The study, to be published in the international journal Science, used data for 25,000 species from The IUCN Red List of Threatened Species™, to investigate the status ...
A new assessment conducted by 174 scientists from around the world underscores a growing concern about the health of the world's biodiversity, quantifying the rate of decline among vertebrate species on a global scale for the first time. The team's results support the idea that our planet is currently experiencing its sixth mass extinction—nearly one fifth of all known vertebrate species are currently classified as Threatened on the International Union for the Conservation of Nature (IUCN) Red List, and an average of 52 species of mammals, birds, and amphibians move one ...
Cutting surveillance for mosquito-borne diseases would likely translate into an exponential increase in both the number of human cases and the health costs when a disease outbreak occurs, according to an analysis by Emory University.
The Public Library of Science (PLoS) publishes the research, led by Emory disease ecologist Gonzalo Vazquez-Prokopec, Oct. 26.
"Our analysis shows that halting mosquito surveillance can increase the management costs of epidemics by more than 300 times, in comparison with sustained surveillance and early case detection," Vazquez-Prokopec ...
An international team of primatologists have discovered a new species of monkey in Northern Myanmar (formerly Burma.) The research, published in the American Journal of Primatology, reveals how Rhinopithecus strykeri, a species of snub-nosed monkey, has an upturned nose which causes it to sneeze when it rains.
Field biologists led by Ngwe Lwin from the Myanmar Biodiversity And Nature Conservation Association and supported by an international team of primatologists from Fauna & Flora International (FFI) and the People Resources and Biodiversity Foundation, discovered the ...
Almost a quarter of colorectal (bowel) cancer cases could be prevented if people followed healthy lifestyle advice in five areas including diet and exercise, says a new study published on bmj.com today.
Researchers from Denmark found that following recommendations on physical activity, waist circumference, smoking, alcohol and diet could reduce the risk of developing bowel cancer considerably – by 23%.
Bowel cancer is the third most common cancer in the UK where more than 38,600 people are diagnosed with the condition every year. It is the second most common cause of ...
Giving people opiate substitution treatment to help with their drug addiction can lead to a 85% plus chance of reducing mortality, according to a new study published on bmj.com today.
Researchers from Bristol and London found that the length of time people had opiate substitution treatment (OST) for had a large impact on its success and the likelihood of death.
Opiate users have a high risk of death, often from overdose.
OST, mostly methadone and buprenorphine, is central to prevention of drug related mortality and often delivered in primary care settings. Over the ...
A new analysis of several major global studies of future species shifts and losses foresees inevitable continuing decline of biodiversity during the 21st century but offers new hope that it could be slowed if emerging policy choices are pursued.
Led by experts Henrique Miguel Pereira and Paul Leadley, the 23-member scientific team from nine countries, under the auspices of DIVERSITAS, UNEP-WCMC and the secretariat of the CBD compared results from five recent global environmental assessments and a wide range of peer-reviewed literature examining likely future changes in ...
Increasing numbers of birds, mammals and amphibians have moved closer to extinction in the last several decades—but not as far as they would have if no conservation measures at all had been enacted, researchers report.
Their study is being published online by the journal Science, at the Science Express Web site, at 6:30 p.m., U.S. Eastern Time, Tuesday, 26 October. Science is the journal of AAAS, the nonprofit science society.
To assess the status of the world's vertebrates, a large, international research team lead by Michael Hoffmann of the International Union for ...
